These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34536671)

  • 1. Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation.
    Padalino G; El-Sakkary N; Liu LJ; Liu C; Harte DSG; Barnes RE; Sayers E; Forde-Thomas J; Whiteland H; Bassetto M; Ferla S; Johnson G; Jones AT; Caffrey CR; Chalmers I; Brancale A; Hoffmann KF
    Eur J Med Chem; 2021 Dec; 226():113823. PubMed ID: 34536671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quorum sensing N-Acyl homoserine lactones are a new class of anti-schistosomal.
    Whiteland H; Crusco A; Bloemberg LW; Tibble-Howlings J; Forde-Thomas J; Coghlan A; Murphy PJ; Hoffmann KF
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008630. PubMed ID: 33075069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
    Whatley KCL; Padalino G; Whiteland H; Geyer KK; Hulme BJ; Chalmers IW; Forde-Thomas J; Ferla S; Brancale A; Hoffmann KF
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007693. PubMed ID: 31730617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of Quinoxaline, Nitroquinoxaline, and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni.
    Debbert SL; Hintz MJ; Bell CJ; Earl KR; Forsythe GE; Häberli C; Keiser J
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33257453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.
    Xiao SH
    Parasitol Res; 2013 Nov; 112(11):3723-40. PubMed ID: 23979493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum.
    Zheng Y; Dong L; Hu C; Zhao B; Yang C; Xia C; Sun D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4223-6. PubMed ID: 25127102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hit compounds with anti-schistosomal activity on in vitro generated juvenile worms in cell-free medium.
    Vejzagić N; Prodjinotho UF; El-Khafif N; Huang R; Simeonov A; Spangenberg T; Prazeres da Costa C
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009432. PubMed ID: 34033658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.
    Cribb DM; Clarke NE; Doi SAR; Vaz Nery S
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007808. PubMed ID: 31603895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.
    Sundaraneedi MK; Tedla BA; Eichenberger RM; Becker L; Pickering D; Smout MJ; Rajan S; Wangchuk P; Keene FR; Loukas A; Collins JG; Pearson MS
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006134. PubMed ID: 29240773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Praziquantel: a new hope for schistosomiasis.
    Lancet; 1980 Mar; 1(8169):635-6. PubMed ID: 6102634
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
    Koehne E; Zander N; Rodi M; Held J; Hoffmann W; Zoleko-Manego R; Ramharter M; Mombo-Ngoma G; Kremsner PG; Kreidenweiss A
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009511. PubMed ID: 34166393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
    Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
    Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of curcumin on Schistosoma species viability, tegument ultrastructure and egg hatchability.
    Abou El Dahab MM; Shahat SM; Mahmoud SSM; Mahana NA
    Exp Parasitol; 2019 Apr; 199():1-8. PubMed ID: 30790572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.